BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4757253)

  • 1. Glucagon and isoproterenol in reversing propranolol toxicity.
    Kosinski EJ; Malindzak GS
    Arch Intern Med; 1973 Dec; 132(6):840-3. PubMed ID: 4757253
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacologic antagonism of propranolol in dogs. III. Effects of dopamine-isoproterenol and glucagon on hemodynamics and myocardial oxygen consumption in ischemic hearts during chronic propranolol administration.
    Wei J; Spotnitz HM; Spotnitz WD; Benvenisty AI; Haasler GB; Malm JR; Hoffman BF
    J Thorac Cardiovasc Surg; 1984 May; 87(5):732-42. PubMed ID: 6717051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of isoproterenol, l-norepinephrine, and glucagon on myocardial gas tensions in animals with coronary artery stenosis.
    Furuse A; Brawley RK; Gott VL
    J Thorac Cardiovasc Surg; 1973 May; 65(5):815-24. PubMed ID: 4696881
    [No Abstract]   [Full Text] [Related]  

  • 4. Glucagon: its mechanism of action on the coronary circulation in the conscious dog.
    Terry B; White FC; Bloor CM
    Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):383-9. PubMed ID: 5074531
    [No Abstract]   [Full Text] [Related]  

  • 5. Action of glucagon on canine left ventricular performance and coronary hemodynamics.
    Abel FL
    Circ Shock; 1983; 11(1):45-58. PubMed ID: 6640854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary vascular and cardiac effects of glucagon before and after adrenergic beta-receptor blockade.
    Madan BR; Gupta RS; Jain BK
    Indian J Physiol Pharmacol; 1971 Oct; 15(4):173-7. PubMed ID: 4401547
    [No Abstract]   [Full Text] [Related]  

  • 7. [Action of ouabain on experimental cardiac depression induced by propranolol in dogs].
    Laubie M; Drouillat M; Roblin M
    Arch Int Pharmacodyn Ther; 1971 Jan; 189(1):183-91. PubMed ID: 4943207
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of glucagon on calcium exchangeability, coronary blood flow, myocardial function and high energy phosphate stores.
    Nayler WG; McInnes I; Chipperfield D; Carson V; Daile P
    J Pharmacol Exp Ther; 1970 Feb; 171(2):265-75. PubMed ID: 5459062
    [No Abstract]   [Full Text] [Related]  

  • 9. Antagonism of chronic canine beta-adrenergic blockade with dopamine-isoproterenol, dobutamine, and glucagon.
    Benvenisty AI; Spotnitz HM; Rose EA; Malm JR; Hoffman BF
    Surg Forum; 1979; 30():187-8. PubMed ID: 538590
    [No Abstract]   [Full Text] [Related]  

  • 10. [Glucagon: effects on hemodynamics and myocardial metabolism].
    Moret P; Duchosal F; Steinmann JM
    Arch Mal Coeur Vaiss; 1972 Aug; 65(8):971-9. PubMed ID: 4633640
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of the central action of propranolol on coronary circulation in dogs].
    Xie BZ; Hu GJ; Yuan LX; Wang H; Jiang WD
    Zhongguo Yao Li Xue Bao; 1985 Mar; 6(1):33-6. PubMed ID: 3158156
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs.
    Vatner SF; McRitchie RJ; Braunwald E
    J Clin Invest; 1974 May; 53(5):1265-73. PubMed ID: 4825224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional blood flow and cardiac responses to hydralazine.
    Spokas EG; Wang HH
    J Pharmacol Exp Ther; 1980 Feb; 212(2):294-303. PubMed ID: 7351643
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of glucagon-induced changes in rate, contractility and cyclic AMP levels in isolated cardiac preparations of the rat and guinea pig.
    MacLeod KM; Rodgers RL; McNeill JH
    J Pharmacol Exp Ther; 1981 Jun; 217(3):798-804. PubMed ID: 6262497
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of changes in myocardial contractility on intramyocardial diastolic pressure].
    Cartes MF; Donoso R; Cabezas MP; Domenech RJ
    Rev Med Chil; 1981 Oct; 109(10):929-34. PubMed ID: 7344016
    [No Abstract]   [Full Text] [Related]  

  • 16. Myocardial lipid peroxidation during isoproterenol-induced blood flow reduction in rat myocardium.
    Blasig IE; Blasig R; Löwe H
    Biomed Biochim Acta; 1984; 43(8-9):S171-4. PubMed ID: 6440536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of isoproterenol on coronary blood flow and signal transduction responses in thyroxine-treated rabbit hearts.
    Rodriguez E; Weiss HR; Gonzalez M; Tse J
    J Mol Cell Cardiol; 1993 Aug; 25(8):939-47. PubMed ID: 8263963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary vascular effects of glucagon in the isolated dog heart.
    Moir TW; Naylor WG
    Circ Res; 1970 Jan; 26(1):29-34. PubMed ID: 4983016
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of glucagon on the perfused rat hind-quarter vessles and on perfused coronary arteries of rabbit.
    Singh J; Bala S; Kaur AH; Garg KN
    Indian J Physiol Pharmacol; 1980; 24(1):68-70. PubMed ID: 7364464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intracoronary propranolol on coronary blood flow and regional myocardial function in dogs.
    Noguchi K; Sunagawa R; Kato T; Nagamine F; Sakanashi M
    Eur J Pharmacol; 1987 Dec; 144(2):201-10. PubMed ID: 3436367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.